Serveur d'exploration SRAS - Analysis (2020)

Index « AbsEn.i » - entrée « help »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
helix < help < helped  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 38.
[0-20] [0 - 20][0 - 38][20-37][20-40]
Ident.Authors (with country if any)Title
000043 (2020) Specialized Committee Of Neurogenetics Neurophysician Branch Of Chinese Medical Doctor Association [République populaire de Chine] ; Hong Jiang ; Beisha Tang[Expert consensus on the management strategy of patients with hereditary ataxia during prevention and control of novel coronavirus pneumonia epidemic].
000090 (2020) Pengfei Sun [République populaire de Chine] ; Xiaosheng Lu [République populaire de Chine] ; Chao Xu [République populaire de Chine] ; Wenjuan Sun [République populaire de Chine] ; Bo Pan [République populaire de Chine]Understanding of COVID-19 based on current evidence.
000137 (2020) Huipeng Ge ; Xiufen Wang ; Xiangning Yuan ; Gong Xiao ; Chengzhi Wang ; Tianci Deng ; Qiongjing Yuan ; Xiangcheng XiaoThe epidemiology and clinical information about COVID-19
000149 (2020) Y J Duan [République populaire de Chine] ; Q. Liu [République populaire de Chine] ; S Q Zhao [République populaire de Chine] ; F. Huang [République populaire de Chine] ; L. Ren [République populaire de Chine] ; L. Liu [République populaire de Chine] ; Y W Zhou [République populaire de Chine]The Trial of Chloroquine in the Treatment of Corona Virus Disease 2019 (COVID-19) and Its Research Progress in Forensic Toxicology.
000158 (2020) Peter J. Hotez ; Maria Elena Bottazzi ; David B. CorryThe Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement
000179 (2020) Pranab Chatterjee [Inde] ; Nazia Nagi [Inde] ; Anup Agarwal [Inde] ; Bhabatosh Das [Inde] ; Sayantan Banerjee [Inde] ; Swarup Sarkar [Inde] ; Nivedita Gupta [Inde] ; Raman R. Gangakhedkar [Inde]The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence.
000251 (2020) Shu-Ren Li [République populaire de Chine] ; Zi-Jian Tang [République populaire de Chine] ; Zai-Han Li [République populaire de Chine] ; Xuan Liu [République populaire de Chine]Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV.
000266 (2020) Osama M. Al-Quteimat [Émirats arabes unis] ; Amer Mustafa Amer [Jordanie]SARS-CoV-2 outbreak: How can pharmacists help?
000283 (2020) Yinon M. Bar-On [Israël] ; Avi Flamholz [États-Unis] ; Rob Phillips [États-Unis] ; Ron Milo [Israël]SARS-CoV-2 (COVID-19) by the numbers.
000299 (2020) Fang Jiang ; Liehua Deng [République populaire de Chine] ; Liangqing Zhang [République populaire de Chine] ; Yin Cai ; Chi Wai Cheung ; Zhengyuan Xia [République populaire de Chine]Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)
000313 (2020) Ka-Tim Choy [République populaire de Chine] ; Alvina Yin-Lam Wong [République populaire de Chine] ; Prathanporn Kaewpreedee [République populaire de Chine] ; Sin Fun Sia [République populaire de Chine] ; Dongdong Chen [République populaire de Chine] ; Kenrie Pui Yan Hui [République populaire de Chine] ; Daniel Ka Wing Chu [République populaire de Chine] ; Michael Chi Wai Chan [République populaire de Chine] ; Peter Pak-Hang Cheung [République populaire de Chine] ; Xuhui Huang [République populaire de Chine] ; Malik Peiris [République populaire de Chine] ; Hui-Ling Yen [République populaire de Chine]Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
000328 (2020) Yushun Wan [États-Unis] ; Jian Shang [États-Unis] ; Rachel Graham [États-Unis] ; Ralph S. Baric [États-Unis] ; Fang Li [États-Unis]Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.
000354 (2020) Pengcheng Zhou [République populaire de Chine] ; Zebing Huang [République populaire de Chine] ; Yinzong Xiao [République populaire de Chine] ; Xun Huang [République populaire de Chine] ; Xue-Gong Fan [République populaire de Chine]Protecting Chinese Healthcare Workers While Combating the 2019 Novel Coronavirus.
000376 (2020) Syed Faraz Ahmed ; Ahmed A. Quadeer ; Matthew R. Mckay [République populaire de Chine]Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
000382 (2020) Ye Qiu ; Yuan-Bo Zhao ; Qiong Wang ; Jin-Yan Li ; Zhi-Jian Zhou ; Ce-Heng Liao ; Xing-Yi GePredicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2
000385 (2020) Giuseppe Rombolà [Italie] ; Marco Hedemperger [Italie] ; Luciano Pedrini [Italie] ; Marco Farina [Italie] ; Filippo Aucella [Italie] ; Piergiorgio Messa [Italie] ; Giuliano Brunori [Italie]Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy
000387 (2020) Farid Rahimi [Australie] ; Amin Talebi Bezmin Abadi [Iran]Practical Strategies Against the Novel Coronavirus and COVID-19-the Imminent Global Threat.
000418 (2020) Balamurugan Shanmugaraj [Thaïlande] ; Konlavat Siriwattananon [Thaïlande] ; Kittikhun Wangkanont [Thaïlande] ; Waranyoo Phoolcharoen [Thaïlande]Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
000444 (2020) Arinjay Banerjee [Canada] ; Michelle L. Baker [Australie] ; Kirsten Kulcsar [États-Unis] ; Vikram Misra [Canada] ; Raina Plowright [États-Unis] ; Karen Mossman [Canada]Novel Insights Into Immune Systems of Bats
000463 (2020) Mirko Baglivo [Italie] ; Manuela Baronio [Italie] ; Giuseppe Natalini [Italie] ; Tommaso Beccari [Italie] ; Pietro Chiurazzi [Italie] ; Ezio Fulcheri [Italie] ; Paolo Pietro Petralia [Italie] ; Sandro Michelini [Italie] ; Giovanni Fiorentini [Italie] ; Giacinto Abele Miggiano [Italie] ; Assunta Morresi [Italie] ; Gerolamo Tonini [Italie] ; Matteo Bertelli [Italie]Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?
000484 (2020) Marco Colizzi [Italie, Royaume-Uni] ; Riccardo Bortoletto ; Marta Silvestri ; Federica Mondini ; Elena Puttini ; Chiara Cainelli ; Rossella Gaudino [Italie] ; Mirella Ruggeri [Italie] ; Leonardo ZoccanteMedically unexplained symptoms in the times of Covid-19 pandemic: a case-report

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "help" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "help" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    help
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021